Inflammation and Pathogenesis Training Program
炎症与发病机制培训计划
基本信息
- 批准号:9753922
- 负责人:
- 金额:$ 13.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-01 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Abstract
The major objective of this new training program is to produce skilled, rigorous, and creative scientists who will
make novel connections between inflammatory processes and human pathogenesis. The University of
Louisville is well-positioned to have high impact by selecting trainees with leadership potential from its existing
Integrated Programs in Biomedical Sciences (IPIBS) for continued training on research topics that bridge
microbiology and immunology. This interdisciplinary approach will bring together 35 faculty who are all highly
productive scientists with extensive mentoring experience, and well-funded research programs, focused on i)
inflammatory ontogeny and immune surveillance of cancer, ii) mechanisms of autoimmune disorders, iii)
cellular and molecular mechanisms of host-microbial interactions, iv) animal models of infectious disease, v)
the role of the microbiota in regulation of inflammatory diseases, vi) polymicrobial communities and
inflammation, and vii) inflammation-driven disease and its impact on host physiology. Pre-candidacy support
from IPIBS, in which all students receive stipends and benefits funded by the University of Louisville, includes
laboratory rotations, advanced didactic training in immunology; inflammation; microbiology; and pathogenesis.
Pre-candidacy training also includes research survival skills, including grant development and composition,
oral presentations, scientific writing and publishing, professional networking, along with extensive training in
the responsible conduct of research. To attain the highest positive peer-to-peer impact, each year two students
who have demonstrated exceptional performance while successfully completing their first two years of
graduate education as IPIBS Fellows, will be selected for two years of support from the T32 training grant.
Students from diverse backgrounds who show the most potential, based on their achievements as IPIBS
Fellows in graduate coursework, a qualifying exam, and in their research projects, will be selected in order to
foster their academic leadership skills and excellence as research scientists. This additional training will occur
through student organization of a program-specific discussion club, hosting two high profile speakers per year
in disciplines that highlight important relationships between inflammation and pathogenesis and rigorous
review of their research progress by a training mentor and dissertation committee. The program will be
overseen by two Directors working closely with a Steering Committee, including an independent evaluation of
the training program’s organization, leadership, objectives and outcomes by Internal and External Advisory
Committees.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NEJAT K EGILMEZ其他文献
NEJAT K EGILMEZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NEJAT K EGILMEZ', 18)}}的其他基金
Oral Immune Modulatory Adjuvants for Treatment of Colorectal Carcinoma
口服免疫调节佐剂治疗结直肠癌
- 批准号:
8268985 - 财政年份:2011
- 资助金额:
$ 13.98万 - 项目类别:
Oral Immune Modulatory Adjuvants for Treatment of Colorectal Carcinoma
口服免疫调节佐剂治疗结直肠癌
- 批准号:
8195792 - 财政年份:2011
- 资助金额:
$ 13.98万 - 项目类别:
Integrating Innate & Adaptive Immunity in Cancer Therapy
整合先天
- 批准号:
6725612 - 财政年份:2004
- 资助金额:
$ 13.98万 - 项目类别:
Integrating Innate & Adaptive Immunity in Cancer Therapy
整合先天
- 批准号:
6896523 - 财政年份:2004
- 资助金额:
$ 13.98万 - 项目类别:
Integrating innate and adaptive immunity in cancer therapy
将先天免疫和适应性免疫整合到癌症治疗中
- 批准号:
8257492 - 财政年份:2004
- 资助金额:
$ 13.98万 - 项目类别:
Integrating Innate & Adaptive Immunity in Cancer Therapy
整合先天
- 批准号:
7227417 - 财政年份:2004
- 资助金额:
$ 13.98万 - 项目类别:
Integrating Innate & Adaptive Immunity in Cancer Therapy
整合先天
- 批准号:
7454186 - 财政年份:2004
- 资助金额:
$ 13.98万 - 项目类别:
Integrating innate and adaptive immunity in cancer therapy
将先天免疫和适应性免疫整合到癌症治疗中
- 批准号:
8462112 - 财政年份:2004
- 资助金额:
$ 13.98万 - 项目类别:
Integrating Innate & Adaptive Immunity in Cancer Therapy
整合先天
- 批准号:
7060822 - 财政年份:2004
- 资助金额:
$ 13.98万 - 项目类别:
Integrating innate and adaptive immunity in cancer therapy
将先天免疫和适应性免疫整合到癌症治疗中
- 批准号:
8096730 - 财政年份:2004
- 资助金额:
$ 13.98万 - 项目类别:
相似海外基金
The mechanism of CELF1 upregulation and its role in the pathogenesis of Myotonic Dystrophy Type 1
CELF1上调机制及其在强直性肌营养不良1型发病机制中的作用
- 批准号:
10752274 - 财政年份:2024
- 资助金额:
$ 13.98万 - 项目类别:
The role of ST6GAL2 and GM3 synthase dysregulation in the pathogenesis of Medulloblastoma. An in-vitro study.
ST6GAL2 和 GM3 合酶失调在髓母细胞瘤发病机制中的作用。
- 批准号:
24K19553 - 财政年份:2024
- 资助金额:
$ 13.98万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The role of proteases in the pathogenesis of DPP4i associated Bullous Pemphigoid
蛋白酶在 DPP4i 相关大疱性类天疱疮发病机制中的作用
- 批准号:
24K19182 - 财政年份:2024
- 资助金额:
$ 13.98万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Role of CD96hi Cells Mediated by Transcription Factor Aryl Hydrocarbon Receptor (AHR) in HIV Pathogenesis.
转录因子芳基烃受体 (AHR) 介导的 CD96hi 细胞在 HIV 发病机制中的作用。
- 批准号:
502605 - 财政年份:2024
- 资助金额:
$ 13.98万 - 项目类别:
Investigation of the pathogenesis and establishing the pharmacotherapy for the early repolarization syndrome and refractory epilepsy caused by KCND3 variants using iPSC models.
使用 iPSC 模型研究 KCND3 变异引起的早期复极综合征和难治性癫痫的发病机制并建立药物治疗。
- 批准号:
24K19074 - 财政年份:2024
- 资助金额:
$ 13.98万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The evolution of host-flavivirus interactions and their impact on viral pathogenesis and host response
宿主-黄病毒相互作用的演变及其对病毒发病机制和宿主反应的影响
- 批准号:
477179 - 财政年份:2023
- 资助金额:
$ 13.98万 - 项目类别:
Operating Grants
Contribution of synovial fibroblast cell subsets to the pathogenesis of knee osteoarthritis
滑膜成纤维细胞亚群对膝骨关节炎发病机制的贡献
- 批准号:
479219 - 财政年份:2023
- 资助金额:
$ 13.98万 - 项目类别:
Operating Grants
NLRC5 isoforms in placental development and pathogenesis of preeclampsia
NLRC5亚型在胎盘发育和先兆子痫发病机制中的作用
- 批准号:
478368 - 财政年份:2023
- 资助金额:
$ 13.98万 - 项目类别:
Operating Grants
Elucidating the Intricate Interplay between Mitochondria, Innate Immunity, and Viral Pathogenesis in Heart Failure
阐明心力衰竭中线粒体、先天免疫和病毒发病机制之间复杂的相互作用
- 批准号:
491149 - 财政年份:2023
- 资助金额:
$ 13.98万 - 项目类别:
Fellowship Programs
The noncanonical roles of FMRP in gating the pathogenesis and rescue of Fragile X Syndrome
FMRP 在控制脆性 X 综合征的发病机制和挽救中的非典型作用
- 批准号:
487764 - 财政年份:2023
- 资助金额:
$ 13.98万 - 项目类别:
Operating Grants